MoonLake Immunotherapeutics News

MoonLake Immunotherapeutics | 8-K: Current report

Mar 11 08:06 ET

MoonLake Immunotherapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF PARTNERS L.P.(34.6%),BVF INC.(34.6%), etc.

Mar 5 17:06 ET

MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Santos da Silva Jorge

Feb 29 19:59 ET

MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reich Kristian

Feb 29 19:54 ET

MoonLake Immunotherapeutics | 10-K: Annual report

Feb 29 08:08 ET

MoonLake Immunotherapeutics | 8-K: Current report

Feb 29 08:08 ET

MoonLake Immunotherapeutics | 8-K: Current report

Feb 26 09:05 ET

MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Santos da Silva Jorge

Feb 23 16:56 ET

MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reich Kristian

Feb 22 18:37 ET

MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Santos da Silva Jorge

Feb 20 18:39 ET

MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reich Kristian

Feb 16 18:07 ET

MoonLake Immunotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 15 16:08 ET

MoonLake Immunotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Merck Healthcare KGaA, Darmstadt Germany an affiliate of Merck KGaA, Darmstadt, Germany(4.7%),Merck KGaA, Darmstadt, Germany(4.7%), etc.

Feb 15 08:07 ET

MoonLake Immunotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 14 18:08 ET

MoonLake Immunotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(3.4%),Citadel Advisors LLC(3.3%), etc.

Feb 14 17:04 ET

MoonLake Immunotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bihua Chen(14.17%)

Feb 14 15:10 ET

MoonLake Immunotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-FMR LLC(6.419%),Abigail P. Johnson(6.419%)

Feb 9 09:34 ET

MoonLake Immunotherapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Bodenstedt Matthias

Dec 21, 2023 16:01 ET

MoonLake Immunotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 20, 2023 16:16 ET

MoonLake Immunotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 19, 2023 16:34 ET